Literature DB >> 1086753

Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient.

W Glinski, M E Gershwin, D R Budman, A D Steinberg.   

Abstract

Peripheral blood lymphocytes of thirty normal volunteers and fifty-two patients with systemic lupus erythematosus were fractionated using a discontinuous (5-30 percent) Ficoll gradient. Such fractionation permitted the isolation, identification of study of null cells, T cells and B cells. Patients with inactive SLE were found to have a cell distribution and responsiveness to PHA, Con A and Pokeweed mitogen (PWM) similar to controls. In contrast, patients with active SLE showed a significant decrease in T-cell fractions as well as a relative increase in null cells, a normal distribution of B cells, a marked reduction in responsiveness to Con A, a lesser reduction to PHA and only a minor reduction to PWM. With increasing disease activity, the number of null cells increased despite lymphopenia. Spontaneous lymphocyte transformation was observed in patients with SLE. This occurred predominantly in the fractions enriched in B cells and was observed both early (0-16 hr) and late (68-72 hr) in the lymphocyte cultures. The method of discontinuous Ficoll gradients is both versatile and reproducible with good correlations between isolated lymphoid subpopulations and disease activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086753      PMCID: PMC1540841     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  DEOXYRIBONUCLEIC ACID SYNTHESIZING CELLS IN THE PERIPHERAL BLOOD OF PATIENTS WITH "AUTO-IMMUNE" DISORDERS.

Authors:  I A COOPER; B G FIRKIN
Journal:  Australas Ann Med       Date:  1965-05

2.  Lymphocyte populations: separation by discontinuous density gradient centrifugation.

Authors:  D T Yu; B J Peter; H E Paulus; H I Machleder
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

3.  Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus.

Authors:  R B Lies; R P Messner; R C Williams
Journal:  Arthritis Rheum       Date:  1973 May-Jun

4.  A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis.

Authors:  A D Steinberg; J L Decker
Journal:  Arthritis Rheum       Date:  1974 Nov-Dec

5.  Cellular immunity in systemic lupus erythematosus.

Authors:  G Senyk; W K Hadley; M R Attias; N Talal
Journal:  Arthritis Rheum       Date:  1974 Sep-Oct

6.  Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus.

Authors:  N Suciu-Foca; J A Buda; T Thiem; K Reemtsma
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

7.  Qualitative characteristics of anti-DNA antibodies in lupus nephritis.

Authors:  M E Gershwin; A D Steinberg
Journal:  Arthritis Rheum       Date:  1974 Nov-Dec

8.  Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.

Authors:  W Glinski; M E Gershwin; A D Steinberg
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

9.  Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.

Authors:  R J Winchester; J B Winfield; F Siegal; P Wernet; Z Bentwich; H G Kunkel
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

10.  Identification and characterization of subpopulations of lymphocytes in human peripheral blood after fractionation on discontinuous gradients of albumin. The cellular defect in X-linked agammaglobulinemia.

Authors:  R S Geha; F S Rosen; E Merler
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

View more
  18 in total

1.  Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.

Authors:  M Koshy; D Berger; M K Crow
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Aqueous multiphase systems of polymers and surfactants provide self-assembling step-gradients in density.

Authors:  Charles R Mace; Ozge Akbulut; Ashok A Kumar; Nathan D Shapiro; Ratmir Derda; Matthew R Patton; George M Whitesides
Journal:  J Am Chem Soc       Date:  2012-05-24       Impact factor: 15.419

3.  T-cell adhesion to endothelial cells in systemic lupus erythematosis.

Authors:  D O Haskard; D Cavender; D Maliakkal; M Ziff
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

4.  A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

Authors:  J J Twomey; A H Laughter; A D Steinberg
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

Review 5.  The use of concanavalin A to study the immunoregulation of human T cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

6.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions.

Authors:  C Morimoto; E L Reinherz; J A Distaso; A D Steinberg; S F Schlossman
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

8.  Autoantibodies against Tmu and B lymphocytes in patients with rheumatoid arthritis.

Authors:  C J Meijer; J Cnossen; G J Lafeber; M J Damsteeg; A Cats
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

9.  Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

10.  Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.

Authors:  H M Moutsopoulos; A S Fauci
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.